Familial hypocalciuric hypercalciemia: clinical case report
https://doi.org/10.14341/osteo13177
Abstract
Hypercalcemia is a laboratory-confirmed syndrome with an increase in blood calcium levels above 2.55 mmol/l. A number of authors claim that the most common causes of hypercalcemia are malignant neoplasms, primary hyperparathyroidism (PHPT), vitamin D intoxication, and chronic kidney disease. One of the rarest causes to consider in patients with newly diagnosed hypercalcemia is familial hypocalciuric hypercalcemia syndrome (FHH). FHH is a genetic autosomal dominant disorder characterized by decreased urinary calcium levels and increased blood calcium levels in combination with normal or above-reference PTH levels. The presented case demonstrates the need to perform a differential diagnosis of hypercalcemia syndrome, the importance of calculating the ratio of renal calcium clearance to creatinine clearance, which is currently the most accessible method and allows one to avoid unjustified parathyroidectomy.
About the Authors
A. S. Sudnitsyna
Tyumen state medical university
Russian Federation
Competing Interests:
Russian Federation
Anna S. Sudnitsyna - MD, PhD.
54 Odesskaya street, 625000 Tyumen
Competing Interests:
None
A. I. Lyapunova
Tyumen state medical university
Russian Federation
Competing Interests:
Russian Federation
Anastasia I. Lyapunova - postgraduate student.
Tyumen
Competing Interests:
None
L. A. Suplotova
Tyumen state medical university
Russian Federation
Competing Interests:
Russian Federation
Lyudmila A. Suplotova - MD, PhD, Professor.
Tyumen
Competing Interests:
None
References
1. Demidova TYu, Lobanova KG, Korotkova TN. Hypercalcemia syndrome: differential diagnostic search and treatment tactics. FOCUS. Endocrinology. 2023;4(1):66-77. (In Russ.) doi: https://doi.org/10.15829/2713-0177-2023-6.
2. Dedov II, Mel’nichenko GA. Endokrinologiya: nacional’noe rukovodstvo. 2-e izd. Moskva: GEOTAR-Media; 2021. — 1112 s. (In Russ.)
3. Banu S, Batool S, Sattar S, Masood MQ. Malignant and Non-Malignant Causes of Hypercalcemia: A Retrospective Study at a Tertiary Care Hospital in Pakistan. Cureus. 2021;13(6):e15845. doi: https://doi.org/10.7759/cureus.15845
4. Tonon CR, Silva TAAL, Pereira FWL, et al. A Review of Current Clinical Concepts in the Pathophysiology, Etiology, Diagnosis, and Management of Hypercalcemia. Med Sci Monit. 2022;28. doi: https://doi.org/10.12659/MSM.935821
5. Turner JJO. Hypercalcaemia - presentation and management. Clin Med (Lond). 2017;17(3):270-273. doi: https://doi.org/10.7861/clinmedicine.17-3-270
6. Adam Z, Starý K, Kubinyi J, Zajíčková K, Řehák Z, et al. Hypercalcemia, symptoms, differential diagnostics and treatment, or importance of calcium investigation. Vnitr Lek. 2016;62(5):370-83
7. Sviridonova MA. Syndrome of hypocalсiuric hypercalcemia. Is it rare? Two clinical cases in an outpatient clinic. Problems of Endocrinology. 2022;68(5):24-31. (In Russ.) doi: https://doi.org/10.14341/probl13125
8. Mokrysheva NG, Eremkina AK, Mirnaya SS, Krupinova JA, Voronkova IA, et al. The clinical practice guidelines for primary hyperparathyroidism, short version. Problems of Endocrinology. 2021;67(4):94-124. (In Russ.) doi: https://doi.org/10.14341/probl12801
9. Zahedi M, Hizomi Arani R, Rafati M, Amouzegar A, Hadaegh F. Persistent hypercalcemia with similar familial Hypocalciuric hypercalcemia features: a case report and literature review. BMC Endocr Disord. 2021;21(1):220. doi: https://doi.org/10.1186/s12902-021-00881-9
10. English KA, Lines KE, Thakker RV. Genetics of hereditary forms of primary hyperparathyroidism. Hormones (Athens). 2024;23(1):3-14. doi: https://doi.org/10.1007/s42000-023-00508-9
11. Taki K, Kogai T, Sakumoto J, Namatame T, Hishinuma A. Familial hypocalciuric hypercalcemia with a de novo heterozygous mutation of calcium-sensing receptor. Endocrinol Diabetes Metab Case Rep. 2015;2015:150016. doi: https://doi.org/10.1530/EDM-15-0016
12. Mullin BH, Pavlos NJ, Brown SJ, Walsh JP, McKellar RA, Wilson SG, Ward BK. Functional Assessment of Calcium-Sensing Receptor Variants Confirms Familial Hypocalciuric Hypercalcemia. J Endocr Soc. 2022;6(5):bvac025. doi: https://doi.org/10.1210/jendso/bvac025
13. Bletsis P, Metzger R, Nelson JA, Gasparini J, Alsayed M, Milas M. A Novel Missense CASR Gene Sequence Variation Resulting in Familial Hypocalciuric Hypercalcemia. AACE Clin Case Rep. 2022;8(5):194-198. doi: https://doi.org/10.1016/j.aace.2022.05.002
14. Kerut S, Kovvuru KR, Yanes-Cardozo L, Garla VV. Familial hypocalciuric hypercalcaemia type 3: AP2S1 missense mutation. BMJ Case Rep. 2020;13(11):e236631. doi: https://doi.org/10.1136/bcr-2020-236631
15. Afzal M, Kathuria P. Familial Hypocalciuric Hypercalcemia. 2023. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. 2024
16. Khadilkar KS, Jagtap V, Lila A, Bandgar T, Shah NS. Utility of cinacalcet in familial hypocalciuric hypercalcemia. Indian Journal of Endocrinology and Metabolism. 2017;21:362–363. doi: https://doi.org/10.4103/2230-8210.202031
17. Mayr BM, Schnabel D, Dörr H-G, Schöfl C. Gain and loss of function mutations of the calcium-sensing receptor and associated proteins: Current treatment concepts. Eur. J. Endocrinol. 2016;174:R189–R208. doi: https://doi.org/10.1530/EJE-15-1028
18. Rasmussen AQ, Jørgensen NR, Schwarz P. Clinical and biochemical outcomes of cinacalcet treatment of familial hypocalciuric hypercalcemia: A case series. J. Med. Case Rep. 2011;5:564. doi: https://doi.org/10.1186/1752-1947-5-564
19. Gorvin CM, Hannan FM, Cranston T, Valta H, Makitie O, Schalin-Jantti C, Thakker RV. Cinacalcet Rectifies Hypercalcemia in a Patient with Familial Hypocalciuric Hypercalcemia Type 2 (FHH2) Caused by a Germline Loss-of-Function Gα11 Mutation. J. Bone Miner. Res. 2018;33:32–41. doi: https://doi.org/10.1002/jbmr.3241
20. Howles S, Hannan F, Babinsky V, Rogers A., Gorvin C, et al. Cinacalcet for Symptomatic Hypercalcemia Caused by AP2S1 Mutations. N. Engl. J. Med. 2016;374:1396–1398. doi: https://doi.org/10.1056/NEJMc1511646
Supplementary files
Review
For citations:
Sudnitsyna A.S., Lyapunova A.I., Suplotova L.A. Familial hypocalciuric hypercalciemia: clinical case report. Osteoporosis and Bone Diseases. 2024;27(4):25-30. (In Russ.) https://doi.org/10.14341/osteo13177
Views:
1201
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
